+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Vasectomy Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 165 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5669249

Vasectomy procedures have been increasing steadily as more individuals and couples choose this permanent form of birth control for family planning.

The Global Vasectomy Market is estimated to be USD 19.74 Bn in 2023 and is expected to reach USD 28.6 Bn by 2028 growing at a CAGR of 7.69%.

  • Vasectomy is a simple and effective male sterilization surgical operation. It involves cutting off or blocking the vas deferens, which are the tubes that transport sperm from the testicles to the penis. This keeps sperm from reaching the sperm, so assuring contraception. It is a permanent method of birth control that has no effect on sexual function.
  • Concerns about overpopulation and its impact on resources and healthcare are growing as the world population grows. Governments and organizations support family planning procedures such as vasectomy to address population growth. Initiatives and programs targeted at increasing sterilization boost awareness of the procedure's safety, effectiveness, and benefits, resulting in increased demand for vasectomy services.
  • Due to their various advantages, such as faster recovery times, reduced pain, and a lower chance of problems, minimally invasive surgical methods are becoming increasingly popular in modern healthcare. As more people seek less invasive methods of birth control, the attraction of vasectomy as a safe and speedy operation has grown, bolstering its commercial demand.
  • Increased investments in R&D efforts, together with technical improvements, represent the market opportunity. As companies and institutions invest more resources in improving vasectomy procedures, such as innovative surgical techniques, advanced medical devices, and improved post-operative care, the overall acceptance and widespread use of vasectomy as a reliable and efficient method of contraception is expected to increase, presenting a positive outlook for the vasectomy market.
  • However, the risk connected with vasectomy operations limits the market. Although typically regarded as safe, consequences such as infection, bleeding, or chronic pain are possible. Fear of these risks could discourage some people from undergoing the operation, so restricting the market's potential growth.
  • The market is hindered by a lack of understanding and a social taboo regarding vasectomy. Misconceptions and a lack of awareness about the procedure's benefits may stymie uptake. Furthermore, cultural stigmas and societal pressures against male sterilization can deter potential candidates, hence limiting market expansion.

Market Segmentations

  • The Global Vasectomy Market is segmented based on Drug, Type, Patients, End Users, and Geography.
  • By Drug, the Global Vasectomy Market is classified into Anesthetics, Antibiotics, and Painkillers.
  • Painkillers hold a larger market share. Painkillers are commonly used to treat a variety of medical illnesses and ailments, ranging from minor to severe pain.
  • By Type, the Global Vasectomy Market is classified into Conventional, Minimally Invasive, and No-Scalpel.
  • Minimally invasive vasectomy holds a significant market share. When compared to conventional and no-scalpel techniques, they provide benefits such as quicker recovery times, less discomfort, and a lesser chance of problems.
  • By Patients, the Global Vasectomy Market is classified into Animal and Human.
  • Humans hold a larger market share. Vasectomy is a widely accepted and commonly utilized method of contraception in humans, whereas vasectomy in animals is mostly employed for population control in specific settings.
  • By End-Users, the Global Vasectomy Market is classified into Hospital & Clinic and Ambulatory Surgical Centers.
  • Hospitals & clinics hold a significant market share. Hospitals offer a wider range of medical treatments and are better able to perform various surgical procedures, such as vasectomy, attracting a larger patient base.
  • By Geography, the Global Vasectomy Market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
  • The Americas hold a larger market share. This is due to reasons such as increased understanding and acceptability of vasectomy as a form of contraception, well-established healthcare infrastructure, and government measures encouraging family planning and population control, all of which are boosting demand in the region.

Recent Development

  • Signature Medical Completes Acquisition of SuperiorVAS Intellectual Property and Technology - December 2022
  • Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal - June 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Accurate Surgical & Scientific Instruments Corp, Sanofi S.A, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Vasectomy Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Vasectomy Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Vasectomy Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
  • Excel data sheet for the market size will also be provided with the report.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
  • The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
  • Market segmentation
  • Competitive Analysis: Comparative analysis of competitor
  • Historical, current, and projected size of the market based on value and volume
  • Market size of the US states
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research0
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Growing Population Concerns and Government Initiative and Program to Encourage Sterilization
4.2.2 Increasing Preference for Minimal Invasive Surgical Procedures
4.3 Restraints
4.3.1 Risk Associated With Vasectomy Surgeries
4.4 Opportunities
4.4.1 Increased Investments to Boost the Research and Development Activities Along with Technological Advancement
4.5 Challenges
4.5.1 Limited Awareness and Social Taboo
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Vasectomy Market, By Drug
6.1 Introduction
6.2 Anesthetics
6.3 Antibiotics
6.4 Painkillers
7 Global Vasectomy Market, By Type
7.1 Introduction
7.2 Conventional
7.3 Minimally Invasive
7.4 No-Scalpel
8 Global Vasectomy Market, By Patients
8.1 Introduction
8.2 Animal
8.3 Human
9 Global Vasectomy Market, By End-Users
9.1 Introduction
9.2 Hospital & Clinic
9.3 Ambulatory Surgical Centers
10 America’s Vasectomy Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas
11 Europe's Vasectomy Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Ireland
11.9 Italy
11.10 Luxembourg
11.11 Netherlands
11.12 Norway
11.13 Poland
11.14 Russia
11.15 Spain
11.16 Sweden
11.17 Switzerland
11.18 United Kingdom
11.19 Rest of Europe
12 Middle East and Africa's Vasectomy Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Nigeria
12.6 Saudi Arabia
12.7 South Africa
12.8 United Arab Emirates
12.9 Rest of MEA
13 APAC's Vasectomy Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific
14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
15 Company Profiles
15.1 Abbott Laboratories
15.1.1 Company Overview
15.1.2 Company Snapshot
15.1.3 Product Overview
15.1.4 Business Overview
15.1.5 SWOT Analysis
15.1.6 Recent Developments
15.2 AbbVie Inc.
15.2.1 Company Overview
15.2.2 Company Snapshot
15.2.3 Product Overview
15.2.4 Business Overview
15.2.5 SWOT Analysis
15.2.6 Recent Developments
15.3 Accurate Surgical & Scientific Instruments Corp.
15.3.1 Company Overview
15.3.2 Company Snapshot
15.3.3 Product Overview
15.3.4 Business Overview
15.3.5 SWOT Analysis
15.3.6 Recent Developments
15.4 Advanced Meditech International Inc
15.4.1 Company Overview
15.4.2 Company Snapshot
15.4.3 Product Overview
15.4.4 Business Overview
15.4.5 SWOT Analysis
15.4.6 Recent Developments
15.5 Allergan PLC
15.5.1 Company Overview
15.5.2 Company Snapshot
15.5.3 Product Overview
15.5.4 Business Overview
15.5.5 SWOT Analysis
15.5.6 Recent Developments
15.6 Bayer AG
15.6.1 Company Overview
15.6.2 Company Snapshot
15.6.3 Product Overview
15.6.4 Business Overview
15.6.5 SWOT Analysis
15.6.6 Recent Developments
15.7 Bristol Myers Squibb
15.7.1 Company Overview
15.7.2 Company Snapshot
15.7.3 Product Overview
15.7.4 Business Overview
15.7.5 SWOT Analysis
15.7.6 Recent Developments
15.8 Cipla Ltd.
15.8.1 Company Overview
15.8.2 Company Snapshot
15.8.3 Product Overview
15.8.4 Business Overview
15.8.5 SWOT Analysis
15.8.6 Recent Developments
15.9 Endo International PLC
15.9.1 Company Overview
15.9.2 Company Snapshot
15.9.3 Product Overview
15.9.4 Business Overview
15.9.5 SWOT Analysis
15.9.6 Recent Developments
15.10 Ferring Pharmaceuticals
15.10.1 Company Overview
15.10.2 Company Snapshot
15.10.3 Product Overview
15.10.4 Business Overview
15.10.5 SWOT Analysis
15.10.6 Recent Developments
15.11 GlaxoSmithKline PLC
15.11.1 Company Overview
15.11.2 Company Snapshot
15.11.3 Product Overview
15.11.4 Business Overview
15.11.5 SWOT Analysis
15.11.6 Recent Developments
15.12 Johnson and Johnson
15.12.1 Company Overview
15.12.2 Company Snapshot
15.12.3 Product Overview
15.12.4 Business Overview
15.12.5 SWOT Analysis
15.12.6 Recent Developments
15.13 Merck & Co., Inc.
15.13.1 Company Overview
15.13.2 Company Snapshot
15.13.3 Product Overview
15.13.4 Business Overview
15.13.5 SWOT Analysis
15.13.6 Recent Developments
15.14 Mylan N.V.
15.14.1 Company Overview
15.14.2 Company Snapshot
15.14.3 Product Overview
15.14.4 Business Overview
15.14.5 SWOT Analysis
15.14.6 Recent Developments
15.15 Novartis AG
15.15.1 Company Overview
15.15.2 Company Snapshot
15.15.3 Product Overview
15.15.4 Business Overview
15.15.5 SWOT Analysis
15.15.6 Recent Developments
15.16 Pfizer, Inc.
15.16.1 Company Overview
15.16.2 Company Snapshot
15.16.3 Product Overview
15.16.4 Business Overview
15.16.5 SWOT Analysis
15.16.6 Recent Developments
15.17 Sanofi S.A.
15.17.1 Company Overview
15.17.2 Company Snapshot
15.17.3 Product Overview
15.17.4 Business Overview
15.17.5 SWOT Analysis
15.17.6 Recent Developments
15.18 Sklar Surgical Instruments
15.18.1 Company Overview
15.18.2 Company Snapshot
15.18.3 Product Overview
15.18.4 Business Overview
15.18.5 SWOT Analysis
15.18.6 Recent Developments
15.19 Sun Pharmaceutical Industries Ltd.
15.19.1 Company Overview
15.19.2 Company Snapshot
15.19.3 Product Overview
15.19.4 Business Overview
15.19.5 SWOT Analysis
15.19.6 Recent Developments
15.20 Teva Pharmaceutical Industries Ltd.
15.20.1 Company Overview
15.20.2 Company Snapshot
15.20.3 Product Overview
15.20.4 Business Overview
15.20.5 SWOT Analysis
15.20.6 Recent Developments
16 Appendix
16.1 Self-Assessment Form

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Accurate Surgical & Scientific Instruments Corp.
  • Advanced Meditech International Inc
  • Allergan PLC
  • Bayer AG
  • Bristol Myers Squibb
  • Cipla Ltd.
  • Endo International PLC
  • Ferring Pharmaceuticals
  • GlaxoSmithKline PLC
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Sklar Surgical Instruments
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.